Detalhe da pesquisa
1.
Management of individuals with germline pathogenic/likely pathogenic variants in CHEK2: A clinical practice resource of the American College of Medical Genetics and Genomics (ACMG).
Genet Med
; 25(10): 100870, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37490054
2.
Management of individuals with germline variants in PALB2: a clinical practice resource of the American College of Medical Genetics and Genomics (ACMG).
Genet Med
; 23(8): 1416-1423, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33976419
3.
Response to Stern.
Genet Med
; 26(2): 101030, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38156990
4.
NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2017.
J Natl Compr Canc Netw
; 15(1): 9-20, 2017 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28040716
5.
Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2015.
J Natl Compr Canc Netw
; 14(2): 153-62, 2016 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-26850485
6.
Genetic/familial high-risk assessment: breast and ovarian, version 1.2014.
J Natl Compr Canc Netw
; 12(9): 1326-38, 2014 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-25190698
7.
Decision making after BRCA genetic testing. Down the road of transition.
Clin J Oncol Nurs
; 18(3): E58-63, 2014 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-24867125
8.
Pyrimidine base damage is increased in women with BRCA mutations.
Cancer Lett
; 338(2): 267-70, 2013 Sep 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-23583677